The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management

References

• Wolfe F, Smythe HA, Yunus MB et al. The American college of rheumatology. criteria for the classification of fibromyalgia. report of the multicenter criteria committee. Arthritis Rheum. 33(2), 160–172 (1990).
   PubMed Web of Science ®Google Scholar
• Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr. Pain Headache Rep. 17(8), 356 (2013).
   PubMed Web of Science ®Google Scholar
• Kindler LL, Bennett RM, Jones KD. Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag. Nurs. 12(1), 15–24 (2011).
   PubMed Web of Science ®Google Scholar
• Salaffi F, Sarzi-Puttini P. Old and new criteria for the classification and diagnosis of fibromyalgia: comparison and evaluation. Clin. Exp. Rheumatol. 30(6 Suppl. 74), 3–9 (2012).
   Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken) 62(5), 600–610 (2010).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 38(6), 1113–1122 (2011).
   PubMed Web of Science ®Google Scholar
• Bazzichi L, Rossi A, Giacomelli C, Bombardieri S. Exploring the abyss of fibromyalgia biomarkers. Clin. Exp. Rheumatol. 28(6 Suppl. 63), S125–S130 (2010).
   Web of Science ®Google Scholar
• Bazzichi L, Sernissi F, Consensi A, Giacomelli C, Sarzi-Puttini P. Fibromyalgia: a critical digest of the recent literature. Clin. Exp. Rheumatol. 29( Suppl. 29), S1–S11 (2011).
   Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology. criteria for the classification of Fibromyalgia. Arthritis Rheum. 33(2), 160–172 (1990).
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. (Hoboken). 62(5), 600–610 (2010).
   PubMed Web of Science ®Google Scholar
• Di Franco M, Iannuccelli C, Bazzichi L et al. Misdiagnosis in fibromyalgia: a multicentre study. Clin. Exp. Rheumatol. 29(6 Suppl. 69), S104–S108 (2011).
   PubMed Web of Science ®Google Scholar
• Gran Jt. The epidemiology of chronic generalised musculoskeletal pain. Best Pract. Res. Clin. Rheumatol. 17(4), 547–561 (2003).
   PubMed Web of Science ®Google Scholar
• Buskila D, Sarzi Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res. Ther. 8(5), 218–222 (2006).
   PubMed Web of Science ®Google Scholar
• Wolfe F. “Silicone related symptoms” are common in patients with fibromyalgia: no evidence for a new disease. J. Rheumatol. 26(5), 1172–1175 (1999).
   PubMed Web of Science ®Google Scholar
• Wilson RB, Gluck OS, Tesser JR, Rice JC, Meyer A, Bridges AJ. Antipolymer antibody reactivity in a subset of patients with fibromyalgia correlates with severity. J. Rheumatol. 26(2), 402–407 (1999).
   Web of Science ®Google Scholar
• Bazzichi L, Giacomelli C, De Feo F et al. Antipolymer antibody in Italian fibromyalgic patients. Arthritis Res.Ther. 9(5), 1478–6354 (2007).
   Google Scholar
• Klein R, Berg PA. High incidence of antibodies to in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur. J. Med. Res. 1(1), 21–26 (1995).
   Google Scholar
• Nishikai M, Tomomatsu S, Hankins RW et al. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology (Oxford) 40(7), 806–810 (2001).
   Web of Science ®Google Scholar
• Smart PA, Waylonis GW, Hackshaw KV. Immunologic profile of patients with fibromyalgia. Am. J. Phys. Med. Rehabil. 76(3), 231–234 (1997).
   PubMed Web of Science ®Google Scholar
• Yunus MB, Hussey FX, Aldag JC. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study. J. Rheumatol. 20(9), 1557–1560 (1993).
   Google Scholar
• Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 79(11), 1136–1144 (2012).
   PubMed Web of Science ®Google Scholar
• Iannuccelli C, Spinelli FR, Guzzo MP et al. Fatigue and widespread pain in systemic lupus erythematosus and Sjögren's syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin. Exp. Rheumatol. 30(6 Suppl. 74), 117–121 (2012).
   Google Scholar
• Dönmez S, Pamuk ÖN, Ümit EG. Top MS. Autoimmune rheumatic disease associated symptoms in fibromyalgia patients and their influence on anxiety, depression and somatisation: a comparative study. Clin. Exp. Rheumatol. 30(6 Suppl. 74), 65–69 (2012).
   Google Scholar
• Costa SP, Lage LV, da Mota LM, de Carvalho JF. Fibromyalgia in primary antiphospholipid (Hughes) syndrome. Lupus 20(11), 1182–1186 (2011).
   Google Scholar
• Priori R, Iannuccelli C, Alessandri C et al. Fatigue in Sjogren's syndrome: relationship with fibromyalgia, clinical and biologic features. Clin. Exp. Rheumatol. 28(6 Suppl. 63), S82–S86 (2010).
   Google Scholar
• Wolfe F, Michaud K, Li T, Katz RS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia. J. Rheumatol. 37(2), 296–304 (2010).
   PubMed Web of Science ®Google Scholar
• Dhir V, Lawrence A, Aggarwal A, Misra R. Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. J. Rheumatol. 36(11), 2443–2448 (2009).
   Google Scholar
• Ranzolin A, Brenol JC, Bredemeier M et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum. 61(6), 794–800 (2009).
   PubMedGoogle Scholar
• Tander B, Cengiz K, Alayli G, Ilhanli I, Canbaz S, Canturk F. A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol. Int. 28(9), 859–865 (2008).
   PubMed Web of Science ®Google Scholar
• Kötter I, Neuscheler D, Günaydin I, Wernet D, Klein R. Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? retrospective analysis with long term follow-up. Rheumatol. Int. 27(11), 1031–1039 (2007).
   Google Scholar
• Magrey MN, Antonelli M, James N, Khan MA. High frequency of fibromyalgia in patients with psoriatic arthritis: a pilot study. Arthritis 2013, 762921 (2013).
   Google Scholar
• Melikoglu M, Melikoglu MA. The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity. Rheumatol. Int. 33(5), 1219–1222 (2013).
   Google Scholar
• Lee SS, Yoon HJ, Chang HK, Park KS. Fibromyalgia in Behçet's disease is associated with anxiety and depression, and not with disease activity. Clin. Exp. Rheumatol. 23(4 Suppl. 38), S15–S19 (2005).
   PubMed Web of Science ®Google Scholar
• Bazzichi L, Rossi A, Zirafa C et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia? Rheumatol. Int. 32(2), 335–341 (2012).
   Google Scholar
• Bazzichi L, Rossi A, Giuliano T et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin. Rheumatol. 26(12), 2115–2120 (2007).
   Web of Science ®Google Scholar
• Suk JH, Lee JH, Kim JM. Association between thyroid autoimmunity and fibromyalgia. Exp. Clin. Endocrinol. Diabetes. 120(7), 401–404 (2012).
   Web of Science ®Google Scholar
• Ribeiro LS, Proietti FA. Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J. Rheumatol. 31(10), 2036–2040 (2004).
   Web of Science ®Google Scholar
• Pamuk ON, Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin. Rheumatol. 26(1), 55–59 (2007).
   PubMed Web of Science ®Google Scholar
• Yanmaz MN, Mert M, Korkmaz M. The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol. Int. 32(4), 871–874 (2012).
   Google Scholar
• Tischler M, Smorodin T, Vazina-Armit M, Ramot Y, Koffler M, Fishel B. Fibromyalgia in diabetes mellitus. Rheumatol. Int. 23(4), 171–173 (2003).
   Google Scholar
• Rao SG, Clauw DJ. The management of fibromyalgia. Drugs Today (Barc.) 40(6), 539–554 (2004).
   PubMed Web of Science ®Google Scholar
• Arnold LM, Lu Y, Crofford LJ et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 50(9), 2974–2984 (2004).
   PubMed Web of Science ®Google Scholar
• Russell IJ, Mease PJ, Smith TR et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 136(3), 432–444 (2008).
   PubMed Web of Science ®Google Scholar
• Westanmo AD, Gayken J, Haight R. Duloxetine: a balanced and selective norepinephrine-and serotoninreuptake inhibitor. Am. J. Health Syst. Pharm. 62(23), 2481–2490 (2005).
   PubMed Web of Science ®Google Scholar
• Gendreau RM, Thorn MD, Gendreau JF et al. Efficacy of Milnacipran in patients with fibromyalgia. J. Rheumatol. 32(10), 1975–1985 (2005).
   PubMed Web of Science ®Google Scholar
• Vitton O, Gendreau M, Gendreau J, Kranzlen J, Rao SG. A double-blind placebo-controlled trial of Milnacipran in the treatment of fibromyalgia. Human Phsychophacol. Clin. Exp. 19( Suppl. 19), 27–35 (2004).
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 52(4), 1264–1273 (2005).
   PubMed Web of Science ®Google Scholar
• Maddali Bongi S, Del Rosso A, Di Felice C, Calà M, Giambalvo Dal Ben G. Rességuier method and Qi Gong sequentially integrated in patients with fibromyalgia syndrome. Clin. Exp. Rheumatol. 30( Suppl. 30), S51–S58 (2012).
   Google Scholar
• Punzi L, Betterle C. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine 71(4), 275–283 (2004).
   Google Scholar